Ameriprise’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Buy |
410,896
+38,543
| +10% | +$133K | ﹤0.01% | 3094 |
|
|
2025
Q1 | $976K | Buy |
372,353
+66,912
| +22% | +$175K | ﹤0.01% | 3192 |
|
|
2024
Q4 | $1.26M | Buy |
305,441
+28,989
| +10% | +$119K | ﹤0.01% | 3114 |
|
|
2024
Q3 | $1.96M | Buy |
276,452
+56,727
| +26% | +$402K | ﹤0.01% | 2922 |
|
|
2024
Q2 | $1.43M | Sell |
219,725
-230,447
| -51% | -$1.5M | ﹤0.01% | 3006 |
|
|
2024
Q1 | $3.74M | Sell |
450,172
-9,371
| -2% | -$77.8K | ﹤0.01% | 2544 |
|
|
2023
Q4 | $5.06M | Buy |
459,543
+364,327
| +383% | +$4.01M | ﹤0.01% | 2341 |
|
|
2023
Q3 | $801K | Buy |
95,216
+6,958
| +8% | +$58.5K | ﹤0.01% | 3236 |
|
|
2023
Q2 | $1.11M | Sell |
88,258
-16,139
| -15% | -$203K | ﹤0.01% | 3125 |
|
|
2023
Q1 | $1.72M | Buy |
104,397
+19,920
| +24% | +$328K | ﹤0.01% | 2909 |
|
|
2022
Q4 | $1.26M | Sell |
84,477
-806
| -0.9% | -$12.1K | ﹤0.01% | 3022 |
|
|
2022
Q3 | $1.91M | Buy |
85,283
+227
| +0.3% | +$5.08K | ﹤0.01% | 2805 |
|
|
2022
Q2 | $1.43M | Buy |
85,056
+12,002
| +16% | +$201K | ﹤0.01% | 2961 |
|
|
2022
Q1 | $2.19M | Buy |
73,054
+8,156
| +13% | +$244K | ﹤0.01% | 2871 |
|
|
2021
Q4 | $1.99M | Buy |
64,898
+21,723
| +50% | +$667K | ﹤0.01% | 2960 |
|
|
2021
Q3 | $1.36M | Buy |
43,175
+3,584
| +9% | +$113K | ﹤0.01% | 3027 |
|
|
2021
Q2 | $1.45M | Buy |
39,591
+3,205
| +9% | +$117K | ﹤0.01% | 3054 |
|
|
2021
Q1 | $1.26M | Sell |
36,386
-7,927
| -18% | -$274K | ﹤0.01% | 3050 |
|
|
2020
Q4 | $1.84M | Sell |
44,313
-1,532
| -3% | -$63.6K | ﹤0.01% | 2832 |
|
|
2020
Q3 | $1.95M | Buy |
+45,845
| New | +$1.95M | ﹤0.01% | 2681 |
|